Cargando…
Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
BACKGROUND: Septic shock is a leading cause of death in critical patients. In patients with gram-negative septic shock, hemoperfusion with polymyxin B aims to remove endotoxins from plasma. We analyzed the clinical and biological response to hemoperfusion in patients with septic shock and acute kidn...
Autores principales: | Navas, Ana, Ferrer, Ricard, Martínez, Maria Luisa, Gomà, Gemma, Gili, Gisela, Masip, Jordi, Suárez, David, Artigas, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286296/ https://www.ncbi.nlm.nih.gov/pubmed/30535929 http://dx.doi.org/10.1186/s13613-018-0465-8 |
Ejemplares similares
-
The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
por: De Rosa, Silvia, et al.
Publicado: (2019) -
Near-infrared spectroscopy StO(2) monitoring to assess the therapeutic effect of drotrecogin alfa (activated) on microcirculation in patients with severe sepsis or septic shock
por: Masip, Jordi, et al.
Publicado: (2013) -
Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock
por: Chu, Laping, et al.
Publicado: (2020) -
Model-based cardiovascular monitoring of large pore hemofiltration during endotoxic shock in pigs
por: Revie, JA, et al.
Publicado: (2011) -
Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)